Edward C. Jauch

Edward C. Jauch

Auto-generated profile, based on publicly available information

Edward C. Jauch

Medical University of South Carolina

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2007 in Stroke
Verified
Journal Article
Closed access
HAHarold P. Adams
Harold P. Adams
GZGregory del Zoppo
Gregory del Zoppo
MAMark J. Alberts
Mark J. Alberts
DBDeepak L. Bhatt
Deepak L. Bhatt
LBLawrence Brass
Lawrence Brass
EWEelco F.M. Wijdicks
Eelco F.M. Wijdicks
Purpose— Our goal is to provide an overview of the current evidence about components of the evaluation and treatment of adults with acute ischemic stroke. The intended audience is physicians and other emergency healthcare providers who treat patients within the first 48 hours after stroke. In addition, information for healthcare policy makers is included. Methods— Members of the panel were appointed by the American Heart Association Stroke Council’s Scientific Statement Oversight Committee and represented different areas of expertise. The panel reviewed the relevant literature with an emphasis on reports published since 2003 and used the American Heart Association Stroke Council’s Levels of Evidence grading algorithm to rate the evidence and to make recommendations. After approval of the statement by the panel, it underwent peer review and approval by the American Heart Association Science Advisory and Coordinating Committee. It is intended that this guideline be fully updated in 3 years. Results— Management of patients with acute ischemic stroke remains multifaceted and includes several aspects of care that have not been tested in clinical trials. This statement includes recommendations for management from the first contact by emergency medical services personnel through initial admission to the hospital. Intravenous administration of recombinant tissue plasminogen activator remains the most beneficial proven intervention for emergency treatment of stroke. Several interventions, including intra-arterial administration of thrombolytic agents and mechanical interventions, show promise. Because many of the recommendations are based on limited data, additional research on treatment of acute ischemic stroke is needed.

2 December 2008 in Circulation
Verified
Journal Article
Closed access
PDF file
RNRobert W. Neumar
Robert W. Neumar
JNJerry P. Nolan
Jerry P. Nolan
CAChristophe Adrie
Christophe Adrie
MAMayuki Aibiki
Mayuki Aibiki
RBRobert A. Berg
Robert A. Berg
THTerry Vanden Hoek
Terry Vanden Hoek

1 February 2011 in Stroke
Verified
Journal Article
Closed access
LGLarry B. Goldstein
Larry B. Goldstein
CBCheryl D. Bushnell
Cheryl D. Bushnell
RARobert J. Adams
Robert J. Adams
LALawrence J. Appel
Lawrence J. Appel
LBLynne T. Braun
Lynne T. Braun
TPThomas A. Pearson
Thomas A. Pearson
Background and Purpose—: This guideline provides an overview of the evidence on established and emerging risk factors for stroke to provide evidence-based recommendations for the reduction of risk of a first stroke. Methods—: Writing group members were nominated by the committee chair on the basis of their previous work in relevant topic areas and were approved by the American Heart Association (AHA) Stroke Council Scientific Statement Oversight Committee and the AHA Manuscript Oversight Committee. The writing group used systematic literature reviews (covering the time since the last review was published in 2006 up to April 2009), reference to previously published guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate recommendations using standard AHA criteria ( Tables 1 and 2 ). All members of the writing group had the opportunity to comment on the recommendations and approved the final version of this document. The guideline underwent extensive peer review by the Stroke Council leadership and the AHA scientific statements oversight committees before consideration and approval by the AHA Science Advisory and Coordinating Committee. Results—: Schemes for assessing a person's risk of a first stroke were evaluated. Risk factors or risk markers for a first stroke were classified according to potential for modification (nonmodifiable, modifiable, or potentially modifiable) and strength of evidence (well documented or less well documented). Nonmodifiable risk factors include age, sex, low birth weight, race/ethnicity, and genetic predisposition. Well-documented and modifiable risk factors include hypertension, exposure to cigarette smoke, diabetes, atrial fibrillation and certain other cardiac conditions, dyslipidemia, carotid artery stenosis, sickle cell disease, postmenopausal hormone therapy, poor diet, physical inactivity, and obesity and body fat distribution. Less well-documented or potentially modifiable risk factors include the metabolic syndrome, excessive alcohol consumption, drug abuse, use of oral contraceptives, sleep-disordered breathing, migraine, hyperhomocysteinemia, elevated lipoprotein(a), hypercoagulability, inflammation, and infection. Data on the use of aspirin for primary stroke prevention are reviewed. Conclusion—: Extensive evidence identifies a variety of specific factors that increase the risk of a first stroke and that provide strategies for reducing that risk.

1 December 2008 in Resuscitation
Verified
Journal Article
Closed access
JNJerry P. Nolan
Jerry P. Nolan
RNRobert W. Neumar
Robert W. Neumar
CAChristophe Adrie
Christophe Adrie
MAMayuki Aibiki
Mayuki Aibiki
RBRobert A. Berg
Robert A. Berg
THTerry Vanden Hoek
Terry Vanden Hoek

22 May 2007 in Circulation
Verified
Journal Article
Closed access
HAHarold P. Adams
Harold P. Adams
GZGregory del Zoppo
Gregory del Zoppo
MAMark J. Alberts
Mark J. Alberts
DBDeepak L. Bhatt
Deepak L. Bhatt
LBLawrence Brass
Lawrence Brass
EWEelco F.M. Wijdicks
Eelco F.M. Wijdicks
Purpose— Our goal is to provide an overview of the current evidence about components of the evaluation and treatment of adults with acute ischemic stroke. The intended audience is physicians and other emergency healthcare providers who treat patients within the first 48 hours after stroke. In addition, information for healthcare policy makers is included. Methods— Members of the panel were appointed by the American Heart Association Stroke Council’s Scientific Statement Oversight Committee and represented different areas of expertise. The panel reviewed the relevant literature with an emphasis on reports published since 2003 and used the American Heart Association Stroke Council’s Levels of Evidence grading algorithm to rate the evidence and to make recommendations. After approval of the statement by the panel, it underwent peer review and approval by the American Heart Association Science Advisory and Coordinating Committee. It is intended that this guideline be fully updated in 3 years. Results— Management of patients with acute ischemic stroke remains multifaceted and includes several aspects of care that have not been tested in clinical trials. This statement includes recommendations for management from the first contact by emergency medical services personnel through initial admission to the hospital. Intravenous administration of recombinant tissue plasminogen activator remains the most beneficial proven intervention for emergency treatment of stroke. Several interventions, including intra-arterial administration of thrombolytic agents and mechanical interventions, show promise. Because many of the recommendations are based on limited data, additional research on treatment of acute ischemic stroke is needed.

1 August 2009 in Stroke
Verified
Journal Article
Closed access
PDF file
GZGregory J. del Zoppo
Gregory J. del Zoppo
JSJeffrey L Saver
Jeffrey L Saver
EJEdward C. Jauch
Edward C. Jauch
HAHarold P. Adams
Harold P. Adams